biotissue-tec-com

© garann

Stain resistant carpet is a great choice, such as among the range of Empire Flooring, because it can make the clean up of spills and messes quick and easy. Even hard to clean stains like red wine on your beige carpet can be cleaned up more easily if your carpet is designed to be stain-resistant. The time it takes to clean up other types of messes like mud, spilled food, pet stains, and more, can be cut down significantly by installing stain-resistant carpet.

While it's true that no carpet is 100% stain-resistant, there are many great options which allow you to remove most stains quickly and easily with no lasting damage to the carpet, such as Empire Today carpet. Most stain-resistant carpet is treated with a special chemical finish to repel dirt and liquids so they don't set into the carpet and cause a stain.

Stain-resistant carpet is made possible by advanced technology. Most stain-resistant carpeting is made from nylon fiber which is treated with a variety of stain-resistant coatings. The major carpet manufacturers use different types of coatings to make their carpets stain-resistant, and each has their own proprietary treatments and application methods.

These tend to fall into two basic categories, depending on the way the nylon fibers are treated. The carpet fibers are either infused with the stain-resistant chemicals before they go to the carpet mill or the chemicals are applied after the carpet has been weaved. The company that you purchase your stain-resistant carpet from should provide you with detailed instructions on proper cleaning methods for removing different types of stains. In many cases, clean up simply involves cleaning with water, or soap and water, as soon as possible.

© jurvetson

Shares of the biotech firm NicOx have been pummeled after an EU panel rejects their anti-inflammatory treatment naproxcinod. The French company said it would drop its European application for the treatment after an expert panel gave it the thumb's down. This comes on the heels of a US FDA rejection as well, and caused shares of the company to drop 34% following the announcement.

The FDA had serious issues with the safety of the non-steroidal anti-inflammatory painkiller, and said that the developer never made a successful case that the new therapy did not raise blood pressure. Hopes had been high that naproxcinod would succeed where Celebrex had failed, and become a blockbuster drug. However, the rejections have instead caused the company to cut its workforce by 50% and abandon its US HQ.

Goodwin Biotechnology, Inc. is a fully integrated contract manufacturer of monoclonal antibodies and vaccines; Goodwin Biotechnology has the experience and expertise in development of recombinant proteins and antibody drug conjugates.

Goodwin Biotechnology has almost 20 years of experience in the field of biotechnology whereas RAFAGEN, Inc. is a well known leader in cell line engineering for protein monoclonal antibody drug production; RAFAGEN's main aim is the development and commercialization of next generation gene expression systems.

PhD, Soo Young Lee, Senior vice president of Goodwin Biotechnology Inc. expressed that by collaborating with RAFAGEN for cell line engineering they can expand their horizons and capabilities as biological contract manufacturing company.
Both the companies recently announced their collaboration agreement for the cell line engineering and biological contract manufacturing.

© Idaho National Laboratory